UK secures European First to lung cancer trial

The UK’s growing reputation for speed and predictability in clinical research is demonstrated through the recruitment of Europe’s first patient to a global lung cancer study in just 110 days by Barts Health NHS Trust. By engaging early with the NIHR Life Sciences Industry Hub, the team was able to rapidly activate the site ahead of 14 other countries.

This success for a study testing a novel oral therapy that could delay the need for chemotherapy shows how the UK’s increased momentum in clinical trial delivery is ensuring UK patients are among the first in Europe to benefit from cutting-edge oncology treatments.